The present invention relates to methods of using tellurium and selenium containing compounds, and particularly to the use of small organic molecules containing tellurium or selenium as exemplified by the compound ammonium-trichloro(dioxoethylene-O,O')tellurate (known by the abbreviation AS101) for treating obesity and obesity related disorders or complications and for reducing of food intake.